Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model.
Saved in:
| Title: | Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model. |
|---|---|
| Authors: | Pokhrel LR; Department of Public Health, The Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA. pokhrell18@ecu.edu., Williams F; Department of Microbiology and Immunology, The Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA., Cook PP; Department of Internal Medicine, The Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA., O'Rourke D; Department of Comparative Medicine, The Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA., Murray G; Department of Pathology & Laboratory Medicine, The Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA., Akula SM; Department of Microbiology and Immunology, The Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA. akulas@ecu.edu. |
| Source: | Drug delivery and translational research [Drug Deliv Transl Res] 2022 Dec; Vol. 12 (12), pp. 3007-3016. Date of Electronic Publication: 2022 Apr 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2190-3948 |
|---|---|
| DOI: | 10.1007/s13346-022-01166-x |
